Abstract
Candida albicans is among the most prevalent opportunistic fungal pathogens. Its capacity to cause life-threatening bloodstream infections is associated with the ability to form biofilms, which are intrinsically drug resistant reservoirs for dispersal. A key regulator of biofilm drug resistance and dispersal is the molecular chaperone Hsp90, which stabilizes many signal transducers. We previously identified 226 C. albicans Hsp90 genetic interactors under planktonic conditions, of which 56 are involved in transcriptional regulation. Six of these transcriptional regulators have previously been implicated in biofilm formation, suggesting that Hsp90 genetic interactions identified in planktonic conditions may have functional significance in biofilms. Here, we explored the relationship between Hsp90 and five of these transcription factor genetic interactors: BCR1, MIG1, TEC1, TUP1, and UPC2. We deleted each transcription factor gene in an Hsp90 conditional expression strain, and assessed biofilm formation and morphogenesis. Strikingly, depletion of Hsp90 conferred no additional biofilm defect in the mutants. An interaction was observed in which deletion of BCR1 enhanced filamentation upon reduction of Hsp90 levels. Further, although Hsp90 modulates expression of TEC1, TUP1, and UPC2 in planktonic conditions, it has no impact in biofilms. Lastly, we probed for physical interactions between Hsp90 and Tup1, whose WD40 domain suggests that it might interact with Hsp90 directly. Hsp90 and Tup1 formed a stable complex, independent of temperature or developmental state. Our results illuminate a physical interaction between Hsp90 and a key transcriptional regulator of filamentation and biofilm formation, and suggest that Hsp90 has distinct genetic interactions in planktonic and biofilm cellular states.
Introduction
Each year, fungi kill as many individuals as malaria or tuberculosis world wide [1]. Fungal pathogenicity is determined by factors that promote survival in and on the host and cause damage [2]. One such key virulence factor is the formation of matrix-associated heterogeneous microbial communities, or biofilms [3], which are observed with the three most common invasive opportunistic fungal pathogens, including Candida albicans [1,4]. This member of the human microbiome [5] forms robust biofilms on medical implant devices where they are associated with mortality rates of up to 50% [6]. Hence, the clinical challenges associated with C. albicans biofilms are severe. Mature biofilms act as reservoirs for dissemination of yeast cells throughout the bloodstream [3], and the capacity to transition between yeast and filamentous forms is important for biofilm maturation [3,7] and virulence [8]. Consequently, biofilms contribute to C. albicans being the fourth most common cause of nosocomial bloodstream infections in the United States, accounting for 8–10% of bloodstream infections [9] and contributing to a 207% increase in fungal sepsis [10]. Eradicating established C. albicans biofilms is almost impossible with currently available antifungal therapies due to intrinsic drug resistance. Minimum inhibitory concentrations of mature biofilms treated with the most widely used antifungal drugs fluconazole and amphotericin B are up to 2,000 times higher than those of planktonic cells [11]. Thus, C. albicans biofilms pose a significant threat to human health necessitating investigations into their molecular and genetic control.
The essential molecular chaperone Hsp90 has emerged as a key regulator of C. albicans drug resistance and morphogenesis in both biofilm and planktonic cellular states [12–14]. Hsp90 interacts with up to 10% of the eukaryotic proteome, comprising mainly signal transducers such as kinases and transcription factors [15]. While Hsp90 is not required for de novo protein folding, it chaperones metastable client proteins and keeps them poised for activation [16]. The first Hsp90 client described in C. albicans is the stress-responsive protein phosphatase calcineurin [17], which enables antifungal drug resistance when stabilized by Hsp90 [12]. Since then, the kinases Cdc28 [18], Mkc1 [19], Cek1 [20], and Hog1 [21] have been shown to require Hsp90 for stability. To date, however, only one C. albicans transcription factor, the heat shock transcription factor 1 (Hsf1), has been shown to physically interact with Hsp90 [20].
To gain a more comprehensive view of the circuitry through which Hsp90 regulates key virulence traits, we previously pioneered a chemical genomic approach to map Hsp90 genetic interactions in C. albicans [21], a pathogen for which the lack of a complete sexual cycle precludes classical genetic approaches. Our screen of a transposon insertion mutant library covering ~10% of the genome revealed 226 Hsp90 chemical genetic interactors, as indicated by hypersensitivity of a mutant to Hsp90 inhibition under at least one of six planktonic conditions screened, including high temperature, mild osmotic stress, and antifungal drugs [21]. Only a few interactors were high connectivity and identified in many conditions, suggesting that they operate upstream of Hsp90 with pleiotropic effects. The majority of the interactors were low connectivity in the network and only identified in one environmental condition, suggesting that they operate downstream of Hsp90. Strikingly, 56 of the Hsp90 genetic interactors identified have functions in transcriptional regulation. Six of these transcriptional regulators have been previously implicated in biofilm formation: one high connectivity Hsp90 interactor, FCR3; and five low connectivity interactors, BCR1, MIG1, TEC1, TUP1, and UPC2. This suggests that the Hsp90 genetic interactions identified in planktonic conditions may have functional significance in the biofilm cellular state. Low connectivity interactors are enriched for downstream effectors of Hsp90 [21], motivating further analysis of the five low connectivity transcriptional regulators implicated in biofilm formation.
Here, we explored functional relationships between Hsp90 and five transcription factor genetic interactors (BCR1, MIG1, TEC1, TUP1, and UPC2) in biofilms and in morphogenesis, a trait important for biofilm maturation and virulence. To do so, we engineered transcription factor gene deletion mutants and assessed their capacity to form biofilms and to filament when HSP90 expression was genetically reduced. Depletion of Hsp90 did not exacerbate the biofilm defect of the mutants. However, an interaction was observed such that deletion of BCR1 enhanced filamentation upon reduction of Hsp90 levels. Further, we found that although depletion of Hsp90 leads to reduced expression of TEC1, TUP1, and UPC2 in planktonic conditions, it has no impact in biofilms. Lastly, to explore the possibility of a physical link between Hsp90 and a transcriptional regulator of biofilm formation, we focused on Tup1 given that it harbors a WD40 domain, which suggests that it might interact with Hsp90 directly [22]. We identified a stable interaction between Hsp90 and Tup1 that was independent of temperature or developmental state. Taken together, our results establish a physical interaction between Hsp90 and a key regulator of morphogenesis and biofilm maturation, and suggest functional divergence in the Hsp90 genetic interaction network between planktonic and biofilm cellular states.
Materials and Methods
Strain maintenance
All strains used here (S1 Table) were made in the wild-type SN95 background [23] or its derivative CaLC432 (MAL2p-HSP90/hsp90∆) [13]. For long-term storage, yeast strains were frozen at -80°C in 25% glycerol. For routine maintenance or in preparation for experiments, strains with wild-type Hsp90 levels were grown in YPD (1% yeast extract, 2% peptone, 2% dextrose) and strains carrying the maltose-inducible promoter upstream of the sole remaining HSP90 allele (MAL2p-HSP90/hsp90∆) were grown in YPM (1% yeast extract, 2% peptone, 2% maltose). To assess the effect of HSP90 depletion, all strains were grown in YPDM (1% yeast extract, 2% peptone, 1% dextrose, 1% maltose).
Strain construction
A PCR-based approach was used to TAP-tag or delete transcription factor genes. Both alleles were deleted by replacement with the recyclable nourseothricin (NAT) selectable marker (pJK863, a gift from J. Koehler). XmaI linearized plasmid at a final concentration of 0.1 ng/μl was used for PCR amplification. TUP1 was tagged with the tandem affinity purification (TAP) tag [24]. Here, pFA-TAP-ARG4 plasmid DNA was diluted 1:100 prior to PCR amplification [25]. Both cassettes were PCR amplified with Q5 High-Fidelity DNA Polymerase (NEB) using primers with 70 bp homology to the target locus (S2 Table). Between 100 and 400 μl ethanol precipitated PCR product were transformed into C. albicans at an optical density between OD600 4 and 8 using the lithium acetate protocol [26]. Following transformation, cells were either incubated for 6 hours at 30°C in YPD or YPM prior to selection on 150 μg/ml NAT or plated immediately onto arginine drop-out medium. Transformation plates were incubated for 3 days at 30°C and transformants re-streaked onto selective media prior to genotyping PCR for the presence of the NAT or pFA-TAP-ARG4 cassette and absence/presence of wild-type alleles (S2 Table). Transformants that tested positive for integration of the NAT marker were cultured in 5 ml YNB-BSA broth (0.17% YNB, 0.4% BSA (Sigma), 0.2% yeast extract, 2% maltose) for 3 days at 30°C to induce expression of the FLP recombinase and excise the NAT marker.
Biofilm formation assays
Biofilm XTT metabolic activity was measured as an indicator of biofilm growth in the wild-type strain SN95, heterozygous and homozygous gene deletion mutants, and mutant strains with reduced Hsp90 levels. XTT activity was determined in two biological replicates with eight technical replicates per strain. On day 1, 96-well plates were filled with 100 μl 5% BSA in 1x PBS and incubated over night at 37°C. C. albicans strains were inoculated in 10 ml YPD or YPM and cultured at 30°C while shaking at 200 rpm overnight. On day 2, 96-well plates were washed once with 1x PBS and filled with 100 μl C. albicans cultures that were adjusted to an OD600 of 0.5 in 1x RPMI 1640 (2% maltose, 0.2% glucose). Following 90 minutes adherence at 37°C, non-adherent cells were removed by vacuum aspiration, wells were refilled with 100 μl 1x RPMI 1640 (2% maltose, 0.2% glucose), and plates incubated for 24 hours at 37°C. On day 3, mature biofilms were washed three times with 1x PBS and metabolic activity assessed with XTT. To do so, 10 ml XTT (BioShop Canada Inc.) stock solution (0.5 mg/ml in 1x PBS) was centrifuged for 5 minutes at 3,000 rpm and the supernatant mixed with 5 μl of 10 mM menadione in ethanol. 100 μl XTT/menadione mixture was added to each well and plates incubated for 15 minutes at 37°C, following which the OD490 was read for each well and the metabolic activity calculated relative to a no-cells control. Statistical significance was evaluated using GraphPad Prism 4.0.
Dry weights of biofilms grown on silicone elastomers (SEs) were determined in two biological replicates, each consisting of five technical replicates. On day 1, 1.5 cm x 2 cm SE pieces were weighed on an analytical scale and one SE was added to each well of a 6-well cell culture plate. Each SE was primed by addition of 4 ml of 5% BSA in 1x PBS and incubated overnight at 37°C without shaking. C. albicans cells were prepared by setting up a standard overnight culture in 10 ml of YPD or YPM while shaking at 200 rpm at 30°C. On Day 2, 6-well dishes were emptied by vacuum aspiration and each SE washed once with 1x PBS. Overnight C. albicans cultures were adjusted to a target OD600 of 0.5 in 1x RPMI 1640 (2% maltose, 0.2% glucose). 4 ml of the adjusted culture was added to five wells while the sixth well served as medium only control. Following adherence at 37°C for 90 minutes, non-adherent cells were removed by vacuum aspiration and wells were refilled with 1x RPMI 1640 (2% maltose, 0.2% glucose). On Day 3, wells were emptied carefully using a serological pipette and SEs placed onto weighted microscope slides to be air-dried for 24 hours. On Day 4, slides with SEs were weighed and dry weight increase assessed as the % weight increase between slide with SE only and slide with SE and dry biofilm.
RNA extraction and quantitative RT-PCR
Expression levels of HSP90, BCR1, MIG1, TEC1, UPC2 and TUP1 were determined in biofilms and planktonic cells cultured in RPMI + 2% maltose and 0.2% glucose. To prepare sufficient cellular material for RNA extraction, biofilms were cultured in 6-well plates as described above and cells harvested from 5 wells after 48 hours of incubation at 37°C. Biofilms were allowed to mature for 48 hours, rather than 24 hours as in the XTT assay, to allow them to fill the much larger 6-well dish. Planktonic cells were started at OD600 0.2 in 50 ml, cultured at 37°C while shaking at 200 rpm and harvested at an OD600 of ~0.8. To measure expression of PCL1, PHO85 and HMS1, the wild-type SN95 and its derivative CaLC2676 (bcr1∆/∆), stationary cultures were adjusted to OD600 0.2 in YPDM and incubated for 6 hours at 30°C consistent with the microscopy conditions (see below).
All cultures were harvested by centrifugation, washed once in 1x PBS, and flash frozen prior to storing pellets at -80°C. RNA was then extracted using the RNeasy mini kit (Qiagen) according to the manufacturers instructions and RNA amounts quantified using the NanoDrop 2000c. Prior to cDNA synthesis, heat-denatured RNA was separated on a 1% agarose gel and 1:5 and 1:200 RNA dilutions tested for genomic DNA contamination by PCR. 1 μg of RNA was subsequently transcribed into cDNA using the AffinityScript Multi-Temp reverse transcriptase kit (Agilent). RT-PCR was conducted on 1:300 dilutions of cDNA using the Fast SYBR Green Master Mix (Life Technologies) according to the manufacturer’s instructions on an Applied Biosystems StepOnePlus Real time PCR System qRT-PCR machine with primers designed using the Primer3web web suite (S2 Table) [27,28]. Expression levels were calculated as mean quantities of three technical replicates relative to the GPD1 control. All qRT-PCR experiments were carried out in at least three biological replicates and statistical significance was evaluated using GraphPad Prism 4.0.
Protein preparation and Western blot analyses
To determine Tup1 protein levels, TAP-tagged strains in the SN95 and MAL2p-HSP90/hsp90∆ backgrounds were grown as described above for RNA extraction and qRT-PCR. Whole cell protein was extracted as described previously [20,29]. Following protein quantification using Bradford reagent (Sigma) [30], between 2 and 20 μg of whole cell protein extract was separated on 6 or 8% SDS-PAGE gels. Separated proteins were transferred to a PVDF membrane for 1 hour at 100 V at 4°C. Membranes were blocked in 5% milk in PBS containing 0.1% Tween-20 at room temperature for one hour and subsequently incubated in primary antibody. All primary antibodies were left on the membrane for one hour at room temperature. Membranes were washed with PBS-T and probed for one hour with secondary antibody dissolved in PBS-T and 5% milk. Membranes were washed in PBS-T and signals detected using an ECL western blotting kit as per the manufacturer’s instructions (Pierce).
TAP-tagged Tup1 was detected using a 1:5,000 dilution of anti-TAP tag rabbit polyclonal antibody (Thermo Scientific; CAB1001) in PBS-T plus 5% milk. To detect Hsp90, a 1:10,000 dilution of anti-Hsp90 antibody was used (courtesy of Bryan Larson) [31] in PBS-T plus 5% milk.
Co-immunoprecipitations
These were performed as described previously [20]. Briefly, C. albicans cultures were grown to OD600 = 0.5, cells harvested, washed with sterile distilled H2O and resuspended in 1 ml lysis buffer (20 mM Tris pH 7.5, 100 mM KCl, 5 mM MgCl2, 20% glycerol, 1 mM PMSF (EMD Chemicals), 20 mM Na2MoO4 (Sigma), and complete EDTA-free protease inhibitor cocktail tablet (Roche Diagnostics). Cells were then disrupted by bead beating twice for 4 minutes with 7 minute breaks on ice between cycles. Lysates were centrifuged at 13,006 g for two-times 5-minutes, recovering the supernatants at each stage. The combined lysate was then cleared by centrifugation at 21,006 g for 10 minutes at 4°C and protein concentrations determined using the Bradford assay. Anti-TAP immunoprecipitations were performed by adjusting protein concentration to 1.5 mg/ml in lysis buffer containing 0.2% Tween, and incubating with Rabbit IgG agarose (Sigma #A2909) at 4°C overnight as per the manufacturer’s specifications. Unbound material was discarded, the beads were washed five times with 1 ml lysis buffer containing 0.1% Tween, and proteins were eluted by boiling in one volume of 2.5% sample buffer (125 mM Tris-HCl, pH 6.8, 5% glycerol, 2.5% SDS, 2.5% beta-mercaptoethanol, distilled H2O, bromophenol blue). Proteins were separated on 8% SDS-PAGE gels and probed as above.
Morphogenesis and analysis of cell morphology by microscopy
We assessed cellular morphology of our transcription factor gene deletion mutants in the wild type (SN95) and the Hsp90 conditional expression background (MAL2p-HSP90/hsp90∆) (S1 Table). Overnight cultures at 30°C and 200 rpm were set up so that strains in the wild-type background were cultured in YPD and strains in the MAL2p-HSP90/hsp90∆ background in YPM at 30°C. To observe morphology in response to Hsp90 depletion in non-filament inducing conditions, overnight cultures were then adjusted to an OD600 of 0.2 in YPDM medium and incubated for 6 hours at 30°C. To determine if changes in cell morphology were specific to Hsp90 depletion, transcription factor deletion mutants in the SN95 wild-type background were tested in canonical filament-inducing conditions, including 10% newborn calf serum (Invitrogen) in YPD, Lee’s Medium [32] and Spider Medium [33]. Strains grown in serum were imaged after 2 hours and those in Lee’s and Spider media after 6 hours. Images were captured using the Differential Interference Contrast setting on the Zeiss Axio Imager.MI microscope together with Axiovision software (Carl Zeiss, Inc.).
Results
Hsp90 interacts with key regulators of biofilm formation
To assess the extent to which Hsp90 interacts with transcriptional regulators, we searched our Hsp90 genetic interaction network for the GO category assignment ‘transcription factor’. Out of a total of 226 genetic interactors [21], 56 fit this GO category and were further analyzed. Network analysis depicts these Hsp90 interactors with respect to the experimental conditions in which each of them was originally identified (Fig 1). The resulting Hsp90 –transcription factor genetic interaction network exhibits similar properties to our full network, with only a few interactors identified in the majority of conditions. The two high-connectivity interactors that were identified in the majority of conditions, AHR1 and FCR3, were previously shown to regulate HSP90 expression [21] or to be required for fluconazole resistance [34] and biofilm adherence [35]. The vast majority of interactors were only identified in one or two environmental conditions, suggesting that they operate downstream of Hsp90.
Based on computational and experimental analyses, this set of 56 genes represents a diverse array of transcription factor classes, many of which have zinc finger domains (Fig 1 inset) (www.candidagenome.org access: May 29th, 2015). While 46% of the Hsp90-interacting transcription factor genes are still considered ‘putative’ or ‘uncharacterized’, others have well-defined functions in biologically diverse processes such as cell wall integrity (ADA2), low-iron response (HAP43), drug response (TAC1), oxidative stress response (CAP1), or transcriptional regulation, as with the SAGA complex (SPT3). Five of the low-connectivity transcription factors that Hsp90 interacts with play some role in biofilm development: BCR1, MIG1, TEC1, TUP1, and UPC2 (Fig 1). These five were identified in the 37°C, 41°C, and fluconazole screens. Growth under basal conditions of 37°C, the prerequisite temperature for biofilm formation, led to the identification of TEC1, MIG1, and UPC2. Growth at an elevated temperature of 41°C, which permits biofilm formation but renders biofilms more drug susceptible [36], yielded UPC2. While, exposure to 0.1 μg/ml fluconazole, to which biofilms are resistant [11], resulted in identification of MIG1, TUP1, and BCR1. These transcription factors have established roles in different aspects of biofilm formation: Bcr1, which is regulated by Tec1, is essential for biofilm initiation and adherence [37]; the transcriptional co-repressor of filamentation Tup1 [38] is down-regulated in mature biofilms [39]; the catabolic repressor Mig1 is overexpressed in biofilms [40]; and the transcriptional regulator of ergosterol biosynthesis genes Upc2 requires Tye7 for normal expression in biofilms [41]. Given their status as low-connectivity interactors in the Hsp90 genetic interaction network, we hypothesized that transcriptional regulators may illuminate circuitry through which Hsp90 influences biofilm biology.
Reduction of Hsp90 levels in transcription factor mutants does not exacerbate biofilm formation defects
Before embarking on functional characterization of the Hsp90-transcription factor relationships and their impact on biofilm formation, we sought to verify our HSP90 depletion system and quantify biofilm growth in response to HSP90 depletion. To reduce HSP90 expression levels, we utilized a conditional expression system in which one allele of HSP90 is deleted and the promoter of the remaining allele is replaced with the MAL2 promoter (MAL2p), which induces transcription in the presence of maltose and represses transcription in the presence of glucose [13]. For long-term repression of HSP90 without detrimental effects on the cell, strains were grown in 1x RPMI 1640 containing 2% maltose and 0.2% glucose. This led to an ~80% decrease in HSP90 levels in planktonic cells (Fig 2A). Strikingly, when we measured HSP90 levels in biofilms, HSP90 expression from the native promoter was ~50% lower compared to that observed in planktonic cells. Expression of HSP90 from the MAL2 promoter was comparable between planktonic and biofilm cellular states. We further corroborated our findings by analysis of Hsp90 protein levels. Hsp90 antibody staining of whole cell protein extracts revealed reduced Hsp90 levels similar to those observed for HSP90 transcript levels (Fig 2B). To ensure cell viability despite severe reduction of Hsp90 levels, planktonic and biofilm cell suspensions were spotted onto YPM and incubated for 48 h. Spot assays indicated vigorous growth in cells with wild-type and genetically reduced Hsp90 levels independent of the developmental program (Fig 2C). Next, we aimed to determine whether reducing Hsp90 levels using the MAL2 promoter would affect biofilm metabolic activity or dry weight in cells cultured in RPMI 1640 (2% maltose, 0.2% glucose) plus maltose. Reduced Hsp90 levels did not affect biofilm growth (Fig 2D and 2E), as expected based on our previous analysis with a different conditional expression system [14]. This provides an approach by which to assess if Hsp90 genetic interactions identified in planktonic cells have functional relevance in the biofilm cellular state.
Upon establishing a reliable Hsp90 depletion system, we sought to determine if reducing HSP90 in transcription factor mutants significantly affected their biofilm development. We first tested heterozygous and homozygous transcription factor gene deletion mutants for their biofilm metabolic activity (Fig 2F). Only the homozygous deletion mutants of BCR1 and UPC2 were unable to form fully active biofilms (Fig 2F). This result confirms BCR1’s involvement in biofilm formation [37], while establishing a new role for UPC2 in C. albicans biofilm development. UPC2 may not have been identified in previous screens for regulators of biofilm formation based on the different culture conditions used. Differences in culture conditions may also account for why we did not identify an impact of TEC1 deletion on biofilm development, despite Tec1 having multiple established roles in biofilm physiology [42–44]. Intriguingly, reducing Hsp90 levels did not further compromise biofilm formation in any of the transcription factor mutant strains tested (Fig 2G). This suggests that Hsp90 may have distinct genetic interactions in biofilm compared to planktonic cellular states, and motivated further analysis of functional relationships between Hsp90 and the transcription factors.
Deletion of BCR1 results in hyperfilamentation upon reduction in Hsp90 levels
To determine if any of the transcription factors modulate filamentation induced upon depletion of Hsp90, we cultured the HSP90 conditional expression strains in glucose-containing medium (YPDM) at 30°C for short-term transcriptional repression of HSP90 and monitored cellular morphology by microscopy. In parallel, we monitored morphology of the transcription factor deletion mutants with native HSP90 levels as a control. The tup1∆/∆ deletion mutant was the only homozygous deletion mutant that filamented in the absence of any inducing cue (S1 Fig); this phenotype was expected given the established role of Tup1 as a transcriptional repressor of filamentation [45]. Homozygous deletion of the transcription factor genes did not alter morphology of the MAL2p-HSP90/hsp90∆ (S1 Fig). Only simultaneous homozygous deletion of BCR1 and depletion of HSP90 resulted in a phenotype different from either single genetic lesion (Fig 3A, S2 Fig). In the absence of Bcr1, the MAL2p-HSP90/hsp90∆ strain exhibited elongated filaments upon Hsp90 depletion (Fig 3A). This result illuminates a new facet of the HSP90 –BCR1 genetic interaction, and suggests that Bcr1 antagonizes Hsp90’s repressive effects on morphogenetic programs.
Next, we tested whether Bcr1 antagonizes filamentation induced by other cues, or whether the effect is specific to Hsp90 compromise. To do so, we cultured the wild-type strain along with the BCR1 heterozygous and homozygous deletion mutants in filament-inducing conditions including 10% serum, Lee’s Medium, and Spider Medium, and imaged cells after two or six hours at 37°C. Loss of BCR1 did not enhance filamentation in response to these cues; rather, filaments were generally shorter and present at a reduced frequency in the population (Fig 3B). Thus, although Bcr1 antagonizes filamentation induced upon Hsp90 depletion, it enhances filamentation in opaque cells [46], and is a positive regulator of hyphal-specific genes [37]; suggesting divergent roles in regulating morphogenesis in response to different cues.
To explore the mechanism by which Bcr1 exerts a repressive effect on morphogenetic circuitry specifically required for response to Hsp90 compromise, we turned to the pathway composed of the cyclin Pcl1, cyclin-dependent kinase Pho85, and transcription factor Hms1. We previously established that signaling through the Pho85-Pcl1-Hms1 pathway is required for filamentation in response to Hsp90 inhibition but not in response to serum, Lee’s Medium, or Spider Medium [47]. To determine if Bcr1 modulates expression of components of this pathway, we measured PHO85, PCL1, and HMS1 transcript levels in wild type and bcr1∆/∆ mutant cells grown in YPD at 30°C. Transcript levels of all three genes were significantly higher in the bcr1∆/∆ mutant compared to the wild type (Fig 3C). This suggests that Bcr1 blocks filamentation in response to Hsp90 depletion by repressing the Pho85-Pcl1-Hms1 pathway.
Hsp90 activates transcription factor gene expression in planktonic cells but not in biofilms
Gene expression profiles differ between planktonic cells and biofilms, with transcription factors being differentially regulated in both cellular states [48]. Given the pivotal role of transcription factor gene expression in biofilm formation, we hypothesized that expression of the five factors investigated here would change between planktonic cells and biofilms. We then aimed to determine if Hsp90 is required for changes in transcription factor gene expression. To do so, RNA from mature biofilms and planktonic cells was extracted and analyzed by qRT-PCR. Only two of our five key transcription factors displayed differential expression between the cellular states; MIG1 [40] and TEC1 were two- to four-fold up-regulated in biofilms relative to planktonic cells (Fig 4A). We found that depletion of Hsp90 functioned as a positive regulator of transcription factor gene expression during planktonic growth, but not in biofilms (Fig 4B and 4C). Depleting Hsp90 in planktonic cells resulted in significantly reduced TEC1, TUP1, and UPC2 gene expression, indicating that Hsp90 is required for full expression of these genes. However, loss of HSP90 had no effect on gene expression of our key transcription factors during biofilm growth. That this functional relationship between Hsp90 and the transcription factor genes is specific to planktonic cells reinforces the notion that genetic interactions are contingent on developmental state.
Tup1 and Hsp90 form a stable interaction independent of environment or developmental state
The regulation of TEC1, TUP1, and UPC2 expression in planktonic conditions confirms that Hsp90 genetically interacts with these three transcription factors, as predicted from the chemical genomic screen originally conducted in planktonic cells [21]. Although, overlap between genetic and physical interactors of Hsp90 is limited [15], Tup1’s WD40 domain has recently been shown to be an Hsp90 client protein fold [49]. Thus, we asked if Hsp90 and Tup1 physically interact, and if Hsp90 modulates stability of Tup1. To do so, we measured Tup1 protein levels in cells with wild type and reduced levels of Hsp90, and conducted a series of co-immunoprecipitation experiments to assess the presence of a physical interaction in different temperatures and developmental states. To determine if Hsp90 is required for Tup1 protein stability, one TUP1 allele was TAP tagged in the wild type and the MAL2p-HSP90 strain, and whole cell proteins were extracted from cells grown at 30°C in YPD. Tup1 protein levels did not decrease when Hsp90 was genetically depleted, suggesting that Hsp90 is not required for Tup1 stability (Fig 5A). Although Tup1 protein levels do not depend on Hsp90, the chaperone may be required for Tup1 maturation. We thus investigated the possibility of an Hsp90-Tup1 physical interaction by co-immunoprecipitating proteins from cells grown at standard temperature (30°C) and at physiological or biofilm-inducing temperature (37°C). At both temperatures, immunoprecipitation of TAP tagged Tup1 with IgG agarose co-purified both TAP-tagged Tup1 and wild-type Hsp90 (Fig 5B). For the control strain lacking the tagged TUP1 allele, Hsp90 was present in the input but was not immunoprecipitated (Fig 5B). Since temperature did not appear to affect the Hsp90- Tup1 interaction, we next tested if it may be contingent on cellular state. To do so, proteins from planktonic and biofilm cells cultured at 37°C were co-immunoprecipitated and processed. Again, Hsp90 co-purified with Tup1, indicating that their interaction is independent of developmental state (Fig 5C). This suggests that while Hsp90 is not required for Tup1 stability, some portion of the Tup1 pool interacts with Hsp90. Thus, Tup1 is a novel Hsp90 interactor whose expression is regulated by Hsp90 in planktonic but not biofilm cells.
Discussion
Our analysis of functional relationships between Hsp90 and transcription factor genetic interactors reveals a stable physical interaction between Hsp90 and a key morphogenetic regulator, and suggests that the Hsp90 genetic interaction network may be exquisitely contingent upon cellular state. Genetic interactions between HSP90 and the biofilm-related transcription factor genes BCR1, MIG1, TEC1, TUP1, and UPC2 that were identified in planktonic conditions (Fig 1), had little impact on fitness of biofilms, such that depletion of HSP90 did not enhance any biofilm defect of the transcription factor deletion mutants (Fig 2). In contrast, an additional interaction was observed in planktonic conditions, such that deletion of BCR1 enhanced filamentation induced by reduction of Hsp90 levels (Fig 3). Consistent with this divergence between interactions in different cellular states, depletion of Hsp90 had no impact on expression of the five transcription factor genes in biofilms, but led to reduced expression of TEC1, TUP1, and UPC2 in planktonic conditions (Fig 4), suggesting that Hsp90 modulates a core transcriptional regulatory circuit during specific developmental programs.
As a central hub of protein homeostasis and regulatory circuitry, Hsp90 is poised to exert a profound impact on transcriptional regulation. There are at least three ways in which Hsp90 tunes transcription [50]. First, Hsp90 modulates activation of diverse transcription factors, thereby enabling transcriptional responses to specific cues [51]. A classic example is with the transcription factor Hsf1; Hsp90 physically interacts with Hsf1 and exerts a repressive effect on this global regulator of the heat shock response, such that compromise of Hsp90 function leads to Hsf1 activation and induction of heat shock genes [20,52,53]. Second, Hsp90 modulates epigenetic gene regulation as it controls the activity of chromatin remodeling factors and epigenetic modifiers, enabling transcriptional responses [50]. This is illustrated by the Hsp90 co-factors Tah1 and Pih1 in S. cerevisiae, which physically interact with Rvb1/Rvb2, core components of several chromatin remodeling factors [15]. Third, Hsp90 is required for removal of nucleosomes from promoter regions of specific genes, thereby enhancing transcriptional activation. In S. cerevisiae, deletion of the Hsp90 gene HSC82 delays nucleosome removal from the GAL1 promoter [54]. Our finding that Hsp90 activates the expression of some but not all of the transcription factor genes in planktonic conditions (Fig 4), suggests that the transcriptional control is specific rather than global in nature. Hsp90 could modulate transcription of these biofilm regulators via multiple mechanisms, with pleiotropic effects expected given that they participate in a highly interconnected network controlling biofilm development [55]. Hsp90 levels are intimately coupled to developmental programs, as they increase during biofilm initiation [56], and decrease accompanying maturation (Fig 2). Beyond expression level, Hsp90 function is also environmentally contingent, such that elevated temperature and other conditions that cause global protein misfolding can create a cellular demand for Hsp90 that exceeds its functional capacity [57]. Thus, Hsp90 provides a powerful mechanism to tune transcriptional circuits in response to environmental conditions and developmental cues.
The interaction between Hsp90 and transcription factors or other client proteins can have multiple functional consequences. Classically, client proteins are defined by a physical interaction with Hsp90 and by activity that is contingent upon Hsp90 function, such that inhibition of Hsp90 leads to reduced client protein activity and often client protein degradation [49,58]. Client proteins often interact dynamically with Hsp90 and co-chaperones, until they achieve their final maturation, localization, or activation. In C. albicans, several Hsp90 client proteins have been characterized, as with the protein phosphatase calcineurin and the terminal MAPK of the cell wall integrity pathway Mkc1 [12,19]. Hsp90 stabilizes these regulators and enables their activation in response to stress in planktonic conditions. Strikingly, depletion of Hsp90 has no impact on their stability in biofilm conditions, suggesting that compensatory mechanisms may buffer client protein stability in the biofilm cellular state [14]. The only transcription factor that has been established as an Hsp90 client protein in C. albicans is Hsf1 [20]. Unlike with many client proteins, Hsp90 interacts robustly with Hsf1 under basal and stress conditions, and Hsp90 exerts a repressive effect on Hsf1 function. Our findings that Hsp90 and Tup1 stably interact in both planktonic and biofilm conditions (Fig 5), suggest that Tup1 may be a novel Hsp90 client protein. Depletion of Hsp90 does not lead to destabilization of Tup1, thus Hsp90 may be involved in localization of Tup1 or modulation of its DNA binding activity. Given that Tup1 works in concert with Nrg1 and Mig1 to regulate expression of the ALS and SAP gene families [59], the physical interaction between Hsp90 and Tup1 links Hsp90 to key regulatory circuitry controlling C. albicans adherence [60], invasion [61], and virulence [62].
The link between Hsp90 and transcriptional circuitry controlling traits relevant for C. albicans pathogenesis further extends to the transcriptional regulator Bcr1 and the capacity for morphological transitions between yeast and filamentous growth. Bcr1 is a downstream component of the filamentation regulatory network as it is upregulated in filaments and promotes adherence through Als3 [3,37]. In addition to its role as a positive regulator coupling the expression of cell surface genes to filamentation, it has emerged as a repressor of filamentation in the C. albicans opaque cellular state [63]. Opaque cells represent a distinct epigenetic switch state from the standard white cells, with white and opaque cells exhibiting distinct programs of filamentous growth that are induced by different cues [64]. Our finding that deletion of BCR1 enhances filamentation that is induced upon depletion of Hsp90 (Fig 3), suggests that Bcr1 may antagonize Hsp90’s repressive effects on morphogenetic programs. Hsp90 is known to control morphogenesis through core pathways involved in filamentation in response to many cues, as together with the co-chaperone Sgt1, it interacts with the adenylyl cyclase Cyr1 and represses Ras1-PKA signaling [65]. Hsp90 also regulates morphogenesis through circuitry that has specialized for responding only to specific filament-inducing cues, as with signaling through the cyclin Pcl1, cyclin-dependent kinase Pho85, and transcription factor Hms1 [47]. Consistent with deletion of BCR1 specifically enhancing filamentation induced by Hsp90 depletion in white cells, Bcr1 exerts a repressive effect on expression of PCL1, PHO85, and HMS1 (Fig 3). With the recent development of pooled screening approaches that enable high-throughput genome-scale analysis of C. albicans morphogenesis [66], we are now poised to elucidate the complex genetic control of filamentation programs that are induced by diverse host relevant cues.
The divergence in filamentation programs induced by different cues and cellular states resonates with the divergence in genetic interaction networks in response to changes in the external or internal environment. The vast majority of Hsp90 genetic interactions are contingent on the environment in which they are measured. This is likely a consequence of condition-specific functions of Hsp90 or the genetic interactor. Consistent with this model, divergence in Hsp90 chemical genetic interactors in S. cerevisiae in response to basal and stress conditions reflects condition-specific functions of Hsp90 [67]. Under basal conditions, Hsp90 has key roles in protein transport and the secretory pathway, as well as stabilizing oligomeric complexes, while in stress conditions, Hsp90 is required for control of cell cycle, meiosis, and cytokinesis [67]. Divergence in genetic interactions in response to environmental conditions or cellular states can also arise from expression or activation of compensatory pathways in a condition-specific manner. In support of this model, it is clear that the majority of transcription factors contain intrinsically disordered domains whose functions are modulated by environmental and developmental contexts, and further controlled by post-translational modification [68]. Our findings that the Hsp90 genetic interaction network may be strikingly different between planktonic and biofilm cellular states, motivates analysis of genetic interaction networks directly in biofilms to elucidate the circuitry governing morphogenesis and drug resistance. Our work complements the emerging paradigm that genetic interaction networks are dynamic and responsive to changes in environmental conditions and development states in diverse species.
Supporting Information
Acknowledgments
We thank Aaron Mitchell for strains and advice, and Cathy Collins for technical support.
Data Availability
All relevant data are within the paper and its Supporting Information files.
Funding Statement
This work was supported by a Prize Fellowship from the University of Bath to SD, a Sir Henry Wellcome Postdoctoral Fellowship (Wellcome Trust 096072) to MDL, a Canada Research Chair in Microbial Genomics and Infectious Disease (303712) to LEC, a Canadian Institutes of Heath Research Operating Grant (MOP-86452) to LEC, a Natural Sciences & Engineering Research Council (NSERC) Discovery Grant (355965) to LEC, and a NSERC E.W.R. Steacie Memorial Fellowship (468732) to LEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1. Brown GD, Denning DW, Gow NAR, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012;4: 165rv13 10.1126/scitranslmed.3004404 [DOI] [PubMed] [Google Scholar]
- 2. Casadevall A, Pirofski LA. Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect Immun. 1999;67: 3703–3713. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Finkel JS, Mitchell AP. Genetic control of Candida albicans biofilm development. Nat Rev Micro. 2011;9: 109–118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Sardi JDCO, Pitangui NDS, Rodriguez-Arellanes G, Taylor ML, Fusco-Almeida AM, Mendes-Giannini MJS. Highlights in pathogenic fungal biofilms. Rev Iberoam Micol. 2014;31: 22–29. 10.1016/j.riam.2013.09.014 [DOI] [PubMed] [Google Scholar]
- 5. Huffnagle GB, Noverr MC. The emerging world of the fungal microbiome. Trends Microbiol. 2013;21: 334–341. 10.1016/j.tim.2013.04.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev. 2004;17: 255–267. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Ramage G, VandeWalle K, Lopez-Ribot JL, Wickes BL. The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans . FEMS Microbiol Lett. 2002;214: 95–100. [DOI] [PubMed] [Google Scholar]
- 8. Saville SP, Lazzell AL, Monteagudo C, Lopez-Ribot JL. Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot Cell. 2003;2: 1053–1060. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 004;39: 309–317. [DOI] [PubMed] [Google Scholar]
- 10. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348: 1546–1554. [DOI] [PubMed] [Google Scholar]
- 11. Hawser SP, Douglas LJ. Resistance of Candida albicans biofilms to antifungal agents in vitro . Antimicrob Agents Chemother. 1995;39: 2128–2131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Singh SD, Robbins N, Zaas AK, Schell WA, Perfect JR, Cowen LE. Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin. PLoS Pathog. 2009;5: e1000532 10.1371/journal.ppat.1000532 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Shapiro RS, Uppuluri P, Zaas AK, Collins C, Senn H, Perfect JR, et al. Hsp90 orchestrates temperature-dependent Candida albicans morphogenesis via Ras1-PKA signaling. Curr Biol. Elsevier; 2009;19: 621–629. 10.1016/j.cub.2009.03.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Robbins N, Uppuluri P, Nett J, Rajendran R, Ramage G, Lopez-Ribot JL, et al. Hsp90 governs dispersion and drug resistance of fungal biofilms. PLoS Pathog. 2011;7: e1002257 10.1371/journal.ppat.1002257 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Zhao R, Davey M, Hsu Y-C, Kaplanek P, Tong A, Parsons AB, et al. Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the Hsp90 chaperone. Cell. 2005;120: 715–727. [DOI] [PubMed] [Google Scholar]
- 16. Nathan DF, Vos MH, Lindquist S. In vivo functions of the Saccharomyces cerevisiae Hsp90 chaperone. Proc Natl Acad Sci USA. 1997;94: 12949–12956. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Cruz MC, Goldstein AL, Blankenship JR, Del Poeta M, Davis D, Cardenas ME, et al. Calcineurin is essential for survival during membrane stress in Candida albicans . EMBO J. 2002;21: 546–559. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Senn H, Shapiro RS, Cowen LE. Cdc28 provides a molecular link between Hsp90, morphogenesis, and cell cycle progression in Candida albicans . Mol Biol Cell. 2012;23: 268–283. 10.1091/mbc.E11-08-0729 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. LaFayette SL, Collins C, Zaas AK, Schell WA, Betancourt-Quiroz M, Gunatilaka AAL, et al. PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90. PLoS Pathog. 2010;6: e1001069 10.1371/journal.ppat.1001069 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Leach MD, Budge S, Walker L, Munro C, Cowen LE, Brown AJP. Hsp90 orchestrates transcriptional regulation by Hsf1 and cell wall remodelling by MAPK signalling during thermal adaptation in a pathogenic yeast. PLoS Pathog. 2012;8: e1003069 10.1371/journal.ppat.1003069 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Diezmann S, Michaut M, Shapiro RS, Bader GD, Cowen LE. Mapping the Hsp90 genetic interaction network in Candida albicans reveals environmental contingency and rewired circuitry. PLoS Genet. 2012;8: e1002562 10.1371/journal.pgen.1002562 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Taipale M, Krykbaeva I, Koeva M, Kayatekin C, Westover KD, Karras GI, et al. Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. Cell. 2012;150: 987–1001. 10.1016/j.cell.2012.06.047 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Noble SM, Johnson AD. Strains and strategies for large-scale gene deletion studies of the diploid human fungal pathogen Candida albicans . Eukaryot Cell. 2005;4: 298–309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Rigaut G, Shevchenko A, Rutz B, Wilm M, Mann M, Séraphin B. A generic protein purification method for protein complex characterization and proteome exploration. Nat Biotechnol. 1999;17: 1030–1032. [DOI] [PubMed] [Google Scholar]
- 25. Lavoie H, Sellam A, Askew C, Nantel A, Whiteway M. A toolbox for epitope-tagging and genome-wide location analysis in Candida albicans . BMC Genomics. 2008;9: 578–590. 10.1186/1471-2164-9-578 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Gietz RD, Schiestl RH. Applications of high efficiency lithium acetate transformation of intact yeast cells using single-stranded nucleic acids as carrier. Yeast. 1991;7: 253–263. [DOI] [PubMed] [Google Scholar]
- 27. Untergasser A, Cutcutache I, Koressaar T, Ye J, Faircloth BC, Remm M, et al. Primer3—new capabilities and interfaces. Nucleic Acids Res. 2012;40: e115–e115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Koressaar T, Remm M. Enhancements and modifications of primer design program Primer3. Bioinformatics. 2007;23: 1289–1291. [DOI] [PubMed] [Google Scholar]
- 29. Leach MD, Cowen LE. Membrane fluidity and temperature sensing are coupled via circuitry comprised of Ole1, Rsp5, and Hsf1 in Candida albicans . Eukaryot Cell. 2014;13: 1077–1084. 10.1128/EC.00138-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72: 248–254. [DOI] [PubMed] [Google Scholar]
- 31. Burt ET, Daly R, Hoganson D, Tsirulnikov Y, Essmann M, Larsen B. Isolation and partial characterization of Hsp90 from Candida albicans . Ann Clin Lab Sci. 2003;33: 86–93. [PubMed] [Google Scholar]
- 32. Lee KL, Buckley HR, Campbell CC. An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida albicans . Sabouraudia. 1975;13: 148–153. [DOI] [PubMed] [Google Scholar]
- 33. Liu H, Köhler J, Fink GR. Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science. 1994;266: 1723–1726. [DOI] [PubMed] [Google Scholar]
- 34. Talibi D, Raymond M. Isolation of a putative Candida albicans transcriptional regulator involved in pleiotropic drug resistance by functional complementation of a pdr1 pdr3 mutation in Saccharomyces cerevisiae . J Bacteriol. 1999;181: 231–240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Finkel JS, Xu W, Huang D, Hill EM, Desai JV, Woolford CA, et al. Portrait of Candida albicans adherence regulators. PLoS Pathog. 2012;8: e1002525 10.1371/journal.ppat.1002525 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Cho T, Nagao J-I, Imayoshi R, Kodama J, Morotomi T, Kaminishi H. In vitro efficacy of continuous mild heat stress on the antifungal susceptibility of Candida albicans biofilm formation. Biol Pharm Bull. 2012;35: 1371–1373. [DOI] [PubMed] [Google Scholar]
- 37. Nobile CJ, Mitchell AP. Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p. Curr Biol. 2005;15: 1150–1155. [DOI] [PubMed] [Google Scholar]
- 38. Braun BR, Head WS, Wang MX, Johnson AD. Identification and characterization of TUP1-regulated genes in Candida albicans . Genetics. 2000;156: 31–44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Nett JE, Lepak AJ, Marchillo K, Andes DR. Time course global gene expression analysis of an in vivo Candida biofilm. J Infect Dis. 2009;200: 307–313. 10.1086/599838 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Garcia-Sanchez S, Aubert S, Iraqui I, Janbon G, Ghigo JM, d'Enfert C. Candida albicans biofilms: a developmental state associated with specific and stable gene expression patterns. Eukaryot Cell. 2004;3: 536–545. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Bonhomme J, Chauvel M, Goyard S, Roux P, Rossignol T, d'Enfert C. Contribution of the glycolytic flux and hypoxia adaptation to efficient biofilm formation by Candida albicans . Mol Microbiol. 2011;80: 995–1013. 10.1111/j.1365-2958.2011.07626.x [DOI] [PubMed] [Google Scholar]
- 42. Daniels KJ, Srikantha T, Pujol C, Park Y-N, Soll DR. Role of Tec1 in the development, architecture, and integrity of sexual biofilms of Candida albicans . Eukaryot Cell. 2015;14: 228–240. 10.1128/EC.00224-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Lin C-H, Kabrawala S, Fox EP, Nobile CJ, Johnson AD, Bennett RJ. Genetic control of conventional and pheromone-stimulated biofilm formation in Candida albicans . PLoS Pathog. 2013;9: e1003305 10.1371/journal.ppat.1003305 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Taff HT, Nett JE, Andes DR. Comparative analysis of Candida biofilm quantitation assays. Med Mycol. 2012;50: 214–218. 10.3109/13693786.2011.580016 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Braun BR, Johnson AD. Control of filament formation in Candida albicans by the transcriptional repressor TUP1 . Science. 1997;277: 105–109. [DOI] [PubMed] [Google Scholar]
- 46. Guan G, Xie J, Tao L, Nobile CJ, Sun Y, Cao C, et al. Bcr1 plays a central role in the regulation of opaque cell filamentation in Candida albicans . Mol Microbiol. 2013;89: 732–750. 10.1111/mmi.12310 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Shapiro RS, Sellam A, Tebbji F, Whiteway M, Nantel A, Cowen LE. Pho85, Pcl1, and Hms1 signaling governs Candida albicans morphogenesis induced by high temperature or Hsp90 compromise. Curr Biol. 2012;22: 461–470. 10.1016/j.cub.2012.01.062 [DOI] [PubMed] [Google Scholar]
- 48. Fanning S. Fungal biofilms. PLoS Pathog. 2012;8: e1002585 10.1371/journal.ppat.1002585 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Taipale M, Jarosz DF, Lindquist S. Hsp90 at the hub of protein homeostasis: emerging mechanistic insights. Nat Rev Mol Cell Biol. 2010;11: 515–528. 10.1038/nrm2918 [DOI] [PubMed] [Google Scholar]
- 50. Khurana N, Bhattacharyya S. Hsp90, the concertmaster: tuning transcription. Front Oncol. 2015;5: 1–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Picard D. Heat-shock protein 90, a chaperone for folding and regulation. Cell Mol Life Sci. 2002;59: 1640–1648. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Duina AA, Kalton HM, Gaber RF. Requirement for Hsp90 and a CyP-40-type cyclophilin in negative regulation of the heat shock response. J Biol Chem. 1998;273: 18974–18978. [DOI] [PubMed] [Google Scholar]
- 53. Zou J, Guo Y, Guettouche T, Smith DF, Voellmy R. Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1. Cell. 1998;94: 471–480. [DOI] [PubMed] [Google Scholar]
- 54. Floer M, Bryant GO, Ptashne M. HSP90/70 chaperones are required for rapid nucleosome removal upon induction of the GAL genes of yeast. Proc Natl Acad Sci USA. 2008;105: 2975–2980. 10.1073/pnas.0800053105 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Nobile CJ, Fox EP, Nett JE, Sorrells TR, Mitrovich QM, Hernday AD, et al. A recently evolved transcriptional network controls biofilm development in Candida albicans . Cell. 2012;148: 126–138. 10.1016/j.cell.2011.10.048 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Becherelli M, Tao J, Ryder NS. Involvement of heat shock proteins in Candida albicans biofilm formation. J Mol Microbiol Biotechnol. 2013;23: 396–400. 10.1159/000351619 [DOI] [PubMed] [Google Scholar]
- 57. Cowen LE. The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype. Nat Rev Micro. 2008;6: 187–198. [DOI] [PubMed] [Google Scholar]
- 58. Leach MD, Klipp E, Cowen LE, Brown AJP. Fungal Hsp90: A biological transistor that tunes cellular outputs to thermal inputs. Nat Rev Micro. 2012;10: 693–704. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Murad AM, d'Enfert C, Gaillardin C, Tournu H, Tekaia F, Talibi D, et al. Transcript profiling in Candida albicans reveals new cellular functions for the transcriptional repressors CaTup1, CaMig1 and CaNrg1. Mol Microbiol. 2001;42: 981–993. [DOI] [PubMed] [Google Scholar]
- 60. Martin R, Wächtler B, Schaller M, Wilson D, Hube B. Host-pathogen interactions and virulence-associated genes during Candida albicans oral infections. Int J Med Microbiol. 2011;301: 417–422. 10.1016/j.ijmm.2011.04.009 [DOI] [PubMed] [Google Scholar]
- 61. Naglik JR, Challacombe SJ, Hube B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev. 2003;67: 400–428 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62. Brown AJP, Brown GD, Netea MG, Gow NAR. Metabolism impacts upon Candida immunogenicity and pathogenicity at multiple levels. Trends Microbiol. 2014;22: 614–622. 10.1016/j.tim.2014.07.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Guan G, Xie J, Tao L, Nobile CJ, Sun Y, Cao C, et al. Bcr1 plays a central role in the regulation of opaque cell filamentation in Candida albicans . Mol Microbiol. 2013;89: 732–750. 10.1111/mmi.12310 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Si H, Hernday AD, Hirakawa MP, Johnson AD, Bennett RJ. Candida albicans white and opaque cells undergo distinct programs of filamentous growth. PLoS Pathog. 2013;9: e1003210–19. 10.1371/journal.ppat.1003210 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Shapiro RS, Zaas AK, Betancourt-Quiroz M, Perfect JR, Cowen LE. The Hsp90 co-chaperone Sgt1 governs Candida albicans morphogenesis and drug resistance. PLoS ONE. 2012;7: e44734 10.1371/journal.pone.0044734 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. O'Meara TR, Veri AO, Ketela T, Jiang B, Roemer T, Cowen LE. Global analysis of fungal morphology exposes mechanisms of host cell escape. Nature Communications. 2015;6: 6741 10.1038/ncomms7741 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67. McClellan AJ, Xia Y, Deutschbauer AM, Davis RW, Gerstein M, Frydman J. Diverse cellular functions of the Hsp90 molecular chaperone uncovered using systems approaches. Cell. 2007;131: 121–135. [DOI] [PubMed] [Google Scholar]
- 68. Niklas KJ, Bondos SE, Dunker AK, Newman SA. Rethinking gene regulatory networks in light of alternative splicing, intrinsically disordered protein domains, and post-translational modifications. Front Cell Dev Biol. 2015;3: 8 10.3389/fcell.2015.00008 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All relevant data are within the paper and its Supporting Information files.